FICIN-DUET Trademark
Trademark Overview
On Thursday, August 11, 1977, a trademark application was filed for FICIN-DUET with the United States Patent and Trademark Office. The USPTO has given the FICIN-DUET trademark a serial number of 73137227. The federal status of this trademark filing is EXPIRED as of Wednesday, March 17, 1999. This trademark is owned by GAMMA BIOLOGICALS, INC.. The FICIN-DUET trademark is filed in the Chemical Products category with the following description:
BIOLOGICAL SERUMS FOR THE DETECTION AND IDENTIFICATION OF BLOOD GROUP ANTIBODIES FOR LABORATORY USE
General Information
Serial Number | 73137227 |
Word Mark | FICIN-DUET |
Filing Date | Thursday, August 11, 1977 |
Status | 900 - EXPIRED |
Status Date | Wednesday, March 17, 1999 |
Registration Number | 1092596 |
Registration Date | Tuesday, June 6, 1978 |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | BIOLOGICAL SERUMS FOR THE DETECTION AND IDENTIFICATION OF BLOOD GROUP ANTIBODIES FOR LABORATORY USE |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 006 |
Class Status Code | 9 - Expired |
Class Status Date | Wednesday, March 17, 1999 |
Primary Code | 001 |
First Use Anywhere Date | Wednesday, January 14, 1976 |
First Use In Commerce Date | Wednesday, June 15, 1977 |
Trademark Owner History
Party Name | GAMMA BIOLOGICALS, INC. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | HOUSTON, TX 77092 |
Trademark Events
Event Date | Event Description |
Wednesday, March 17, 1999 | EXPIRED SEC. 9 |
Monday, April 23, 1984 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |